⚕ GalenOps field
←

715-1405

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
715 (USA) · Dr. Moreau
consented 2013-07-06

AEs
6
Serious
0
Dropout signal
–

Adverse events

moderate assessed

Moderate CONFUSIONAL STATE — outcome: RECOVERED/RESOLVED; onset 2013-07-08 (study day 3.0); relationship: PROBABLE

moderate assessed

Moderate DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-07-08 (study day 3.0); relationship: PROBABLE

moderate assessed

Moderate HYPERHIDROSIS — outcome: RECOVERED/RESOLVED; onset 2013-07-08 (study day 3.0); relationship: PROBABLE

moderate assessed

Moderate PALPITATIONS — outcome: RECOVERED/RESOLVED; onset 2013-07-08 (study day 3.0); relationship: PROBABLE

moderate assessed

Moderate SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-13 (study day 8.0); relationship: NONE

moderate assessed

Moderate SINUS BRADYCARDIA — outcome: RECOVERED/RESOLVED; onset 2013-07-13 (study day 8.0); relationship: NONE

Data queries

No data queries.